Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment

2021 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Histopathological Findings Predict Renal Recovery in Severe ANCA-Associated Vasculitis Requiring Intensive Care Treatment​
Hakroush, S.; Tampe, D. ; Korsten, P. ; Ströbel, P. ; Zeisberg, M.   & Tampe, B. ​ (2021) 
Frontiers in Medicine7.​ DOI: https://doi.org/10.3389/fmed.2020.622028 

Documents & Media

Data_Sheet_1.PDF5.75 MBUnknownfmed-07-622028-g0001.tif835.66 kBUnknownfmed-07-622028-g0002.tif836.95 kBUnknownfmed-07-622028.pdf3.3 MBUnknown

License

Details

Authors
Hakroush, Samy; Tampe, Desiree ; Korsten, Peter ; Ströbel, Philipp ; Zeisberg, Michael ; Tampe, Björn 
Abstract
Renal involvement is a common and severe complication of AAV as it can cause ESRD. Histopathological subgrouping and ARRS are helpful to predict long-term ESRD in patients with AAV. Because a subgroup of critically ill patients with severe AAV present with deterioration of kidney function requiring RRT at admission, we here aimed to evaluate histopathological findings and predictive value of Berden's histopathological subgrouping and ARRS for severity of AKI and requirement of RRT during the short-term clinical course in critically ill patients requiring intensive care treatment and predictors for short-term renal recovery in patients requiring RRT. A subgroup of 15/46 (32. 6%) AAV patients with biopsy-proven AAV required RRT during the short-term course of disease, associated with requirement of critical care treatment. While histopathological subgrouping and ARRS were associated with requirement of acute RRT, presence of global glomerular scarring was the strongest predictor of failure to recover from RRT after initiation of remission induction therapy. This new aspect requires further investigation in a prospective controlled setting for therapeutic decision making especially in this subgroup.
Issue Date
2021
Publisher
Frontiers Media S.A.
Journal
Frontiers in Medicine 
eISSN
2296-858X
Language
English

Reference

Citations


Social Media